Effect of spirulina supplementation in treatment of patients with Alzheimer's disease
Phase 3
Recruiting
- Conditions
- Alzheimer's disease.Alzheimer's disease
- Registration Number
- IRCT20170612034497N6
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with Alzheimer's disease
Individuals aged 55 to 90 years
Exclusion Criteria
Patients with metabolic syndrome
Patients with cardiovascular disease
Patients with chronic infections
Consuming spirulina supplements within 8 weeks prior to the study
Taking antioxidants supplements
Patients with diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Mini Mental State Exam (MMSE).
- Secondary Outcome Measures
Name Time Method